- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
WCRX Market Currents
more »
-
May 4 Warner Chilcott (WCRX): Q1 EPS of $1.16 beats by $0.17. Revenue of $685M (-9.5% Y/Y) misses by $37M. (PR)
Comment![Earnings, Healthcare]
WCRX in Focus
more »
WCRX Related Articles
more »
WCRX News
more »
-
at MarketWatch.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 27, 2012)
-
at MarketWatch.com (Feb 24, 2012)
-
at MarketWatch.com (Nov 4, 2011)
WCRX Press Releases and Filings
more »
-
GlobeNewswire (May 4, 2012)
-
GlobeNewswire (May 1, 2012)
-
GlobeNewswire (Apr 30, 2012)
-
GlobeNewswire (Apr 30, 2012)
-
GlobeNewswire (Apr 26, 2012)
WCRX Latest Transcript
more »
-
Fri, May 4
WCRX Cramer
more »
-
Tue, Oct 5, 2010
-
Fri, Mar 5, 2010
-
Fri, Dec 4, 2009
WCRX Instablog posts
more »
WCRX vs. ETF Alternatives
Company Description
We are a leading global specialty pharmaceutical company currently focused on the gastroenterology, women’s healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. We are a fully integrated company with internal resources dedicated to the... More
